CRL vs IBCP · rev $2.00B vs P/E 10, rev $15.8M
Charles River Laboratories (CRL) versus Independent Bank Corporation (IBCP) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Independent Bank Corporation (IBCP) is a banks - regional company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported IBCP revenue for 2026-06-30 was $15.8M. Net income was $35.7M. IBCP currently screens at market cap $707.2M and trailing P/E 10.3.
CRL currently screens at market cap $7.78B. IBCP currently screens at market cap $707.2M and trailing P/E 10.3.
Not investment advice. Open the CRL and IBCP stock pages for the full models.
Not investment advice.